Most thyroid cancer is very treatable when it is caught early. The most common form, papillary thyroid cancer, has a five-year survival rate above 99% when the disease is still confined to the thyroid. The problem for Black women is not that the cancer is more common. It is that, when it does occur, it is found later, it is more often an aggressive type, and survival is worse. A study of more than 25,000 patients in the federal SEER cancer registry found Black patients were the only group with a clear survival disadvantage after accounting for stage, tumor size, surgery, and socioeconomic factors.
What thyroid cancer is
The thyroid is a butterfly-shaped gland at the base of the neck that makes hormones controlling metabolism. Cancer there comes in four main types, and the type matters more than almost anything else for prognosis. Papillary thyroid cancer is by far the most common, roughly 80% of cases, grows slowly, and is usually very treatable even when it reaches nearby lymph nodes. Follicular thyroid cancer is about 10% of cases and carries a slightly worse outlook. These two are the well-differentiated cancers, and most thyroid cancer is in this group.
The dangerous types are rare. Medullary thyroid cancer is under 5% of cases, can run in families, and is harder to find and treat. Anaplastic thyroid cancer is roughly 2% of cases, spreads fast, and is one of the most aggressive human cancers. The reason the type matters for Black women is that the disparity is partly a subtype problem: Black patients are diagnosed with the aggressive forms more often.
The disparity: less common, but deadlier
The numbers look reassuring at first glance. The American Cancer Society reports thyroid cancer is 40% to 50% less common in Black people than in any other racial or ethnic group. But incidence is not outcome. When researchers followed 26,902 patients diagnosed between 1992 and 2006 in the SEER registry, African American patients had a lower five-year survival rate than white patients (96.5% versus 97.4%). More telling was the disease they presented with: African Americans were 2.3 times more likely to be diagnosed with anaplastic cancer, about 80% more likely to have follicular cancer, and nearly twice as likely to have a large tumor of 4 centimeters or more (Hollenbeak and colleagues, 2011).
A separate analysis of well-differentiated thyroid cancer found Black patients presented with more advanced disease: 7.3% had distant, metastatic spread at diagnosis versus 4.2% of white patients, and their median tumor was 19 millimeters versus 15. After adjusting for age, sex, income, and insurance, Black patients still had a 40% higher risk of dying overall (hazard ratio 1.4), and among patients with metastatic disease, Black patients had the lowest survival (Harari and colleagues, 2014).
The gap is not just biology, and it is not just income. A 2024 study of papillary thyroid cancer found Black and Hispanic patients waited longer for surgery (median 43 and 42 days versus 36 for white patients), and that delay over 90 days was tied to worse survival. But even after the authors accounted for time to surgery and other factors, Black patients still had poorer outcomes (hazard ratio 1.21). A 2023 review in the same journal documented the access side plainly: Black patients had longer waits for referral, received fewer fine-needle biopsies for thyroid nodules, were less likely to get guideline-concordant surgery and radioactive iodine, and were more often operated on by low-volume surgeons. This is the incidence-versus-outcomes paradox, and it is built out of care gaps that compound at every step.
The symptoms and signs to know
Most thyroid cancers are found by accident, on an imaging scan ordered for something else, or as a lump someone notices in the mirror. When there are signs, the most common is a painless lump or nodule in the front of the neck. Others include:
- Hoarseness or voice changes that do not go away
- Trouble swallowing
- A feeling of pressure or fullness in the neck
- Swollen lymph nodes in the neck
- Neck pain that may reach the ears
A lump alone is not a cancer diagnosis. Over 90% of thyroid nodules are benign. But the only way to know is to have it evaluated, and that evaluation is exactly the step Black patients are too often denied or delayed.
How it is different from benign thyroid problems
A thyroid nodule is not the same as thyroid cancer, and neither is the same as the common autoimmune thyroid diseases. Hashimoto's (an underactive thyroid) and Graves' disease (an overactive thyroid) change how much hormone the gland makes; they are about thyroid function, not a tumor. Most nodules are benign growths that never become cancer. If you already manage a thyroid condition, see our explainer on thyroid disease in Black women and our guide to Graves' disease and hyperthyroidism. A new or growing lump in any of these settings still warrants imaging.
Risk factors
The strongest known risk factor is radiation exposure to the head or neck, especially in childhood, which is why people treated with radiation as children carry lifetime risk. Other factors, per the National Cancer Institute, include a family history of thyroid cancer or thyroid disease, certain inherited syndromes (familial medullary thyroid cancer, multiple endocrine neoplasia type 2, familial adenomatous polyposis, Cowden syndrome), a history of goiter, and being between 25 and 65. Female sex is itself a risk factor: thyroid cancer occurs about three times more often in women than in men. If a close relative had medullary thyroid cancer or MEN2, tell your doctor, because that changes the screening conversation.
How thyroid cancer is diagnosed
Diagnosis follows a clear path. A doctor feels the neck, then orders a neck ultrasound, the best first imaging test for sizing a nodule and judging whether it looks suspicious. Suspicious nodules get a fine-needle aspiration biopsy, a thin needle that draws cells for a pathologist to read, and the most reliable way to tell benign from cancer. Thyroid function blood tests (TSH and related hormones) round out the picture, though they cannot diagnose cancer on their own. The two steps that matter most for Black women are the ultrasound and the biopsy, because those are the steps the data show getting skipped or delayed. If you are handed a referral and the appointment is months away, ask to be seen sooner and ask why.
Treatment and prognosis
For most thyroid cancer, treatment works and the prognosis is excellent. The mainstay is surgery to remove part or all of the thyroid (thyroidectomy). Some patients then get radioactive iodine to destroy any remaining thyroid tissue or cancer cells. After the gland is removed, patients take thyroid hormone replacement for life, a single daily pill, and are monitored with blood tests and ultrasound. For papillary cancer, five-year survival is over 99% when the disease is localized or regional, and still about 71% even when it has spread to distant sites. The gap for Black women is not that these treatments fail. It is that the right treatment, by an experienced surgeon, started on time, reaches Black patients less reliably. Knowing that is your leverage to ask for it.
How to get care
The single action that closes the most ground is getting a neck lump imaged and, if needed, biopsied, without a long wait. Ask for an ultrasound by name, and ask to be referred to an endocrinologist or head-and-neck surgeon who does these procedures often, since surgeon experience is tied to better outcomes. You can find a Black endocrinologist or specialist in our directory. If an appointment is set months out, push for an earlier slot; the data on delayed surgery say the wait is not harmless.
Frequently asked questions
Is thyroid cancer less common in Black women? ▼
Yes. The American Cancer Society reports thyroid cancer is 40% to 50% less common in Black people than in any other racial or ethnic group. But Black women who do get it are more likely to be diagnosed at a later stage, to have aggressive subtypes, and to have worse survival, so lower incidence does not mean lower risk of a bad outcome.
Why do Black women have worse thyroid cancer outcomes? ▼
Studies point to a mix of later-stage diagnosis, higher rates of aggressive cancer types like anaplastic and follicular, longer waits for referral and surgery, fewer biopsies for thyroid nodules, and less guideline-concordant treatment. A survival disadvantage remains even after adjusting for stage, treatment, and income, which points to access and care gaps rather than biology alone.
What does a thyroid cancer lump feel like? ▼
It is usually a painless, firm lump or swelling in the front of the neck that may grow over time. It can come with hoarseness, trouble swallowing, neck pressure, or a swollen lymph node. Most neck lumps are benign nodules, but the only way to know is an ultrasound and, if needed, a fine-needle biopsy.
How is thyroid cancer diagnosed? ▼
A clinician examines the neck, orders a neck ultrasound to look at the nodule, and performs a fine-needle aspiration biopsy if the nodule looks suspicious. Thyroid function blood tests add context but cannot diagnose cancer by themselves. The biopsy is the definitive test.
Is thyroid cancer curable? ▼
Most thyroid cancer is highly treatable. Papillary cancer, the most common type, has a five-year survival rate above 99% when caught early and still about 71% even after distant spread. Treatment is usually surgery, sometimes radioactive iodine, then lifelong thyroid hormone replacement and monitoring. Catching it early is what makes the difference.
